Haleon PLC Sponsored ADR (NYSE:HLN) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Haleon PLC Sponsored ADR (NYSE:HLN) has been given an average recommendation of “Moderate Buy” by the nine research firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating, three have assigned a buy rating and two have assigned a strong buy rating to the company.

Several equities analysts have weighed in on HLN shares. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a research note on Tuesday, June 30th. Rothschild & Co Redburn lowered Haleon from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, June 16th. Wall Street Zen raised Haleon from a “hold” rating to a “buy” rating in a research note on Sunday. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Haleon in a research report on Thursday, April 30th. Finally, Argus raised shares of Haleon to a “strong-buy” rating in a research note on Tuesday, March 17th.

Haleon Stock Down 1.5%

Shares of Haleon stock opened at $9.71 on Wednesday. The company has a quick ratio of 0.71, a current ratio of 0.92 and a debt-to-equity ratio of 0.47. Haleon has a 12 month low of $8.65 and a 12 month high of $11.28. The business has a fifty day simple moving average of $9.22 and a 200 day simple moving average of $9.86. The stock has a market cap of $42.79 billion, a PE ratio of 24.91, a price-to-earnings-growth ratio of 2.28 and a beta of 0.13.

Institutional Investors Weigh In On Haleon

Hedge funds have recently bought and sold shares of the company. Parkside Financial Bank & Trust boosted its position in shares of Haleon by 101.3% during the fourth quarter. Parkside Financial Bank & Trust now owns 2,847 shares of the company’s stock worth $29,000 after purchasing an additional 1,433 shares in the last quarter. Western Wealth Management LLC acquired a new position in shares of Haleon in the 1st quarter valued at $29,000. Annis Gardner Whiting Capital Advisors LLC increased its position in shares of Haleon by 402.0% in the 1st quarter. Annis Gardner Whiting Capital Advisors LLC now owns 3,002 shares of the company’s stock valued at $30,000 after buying an additional 2,404 shares in the last quarter. Stance Capital LLC bought a new stake in shares of Haleon in the 3rd quarter valued at $34,000. Finally, Geneos Wealth Management Inc. raised its stake in Haleon by 33.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock worth $50,000 after buying an additional 1,203 shares during the period. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.